Bumrungrad Hospital PCLBUGDF 100 ROE % is 25.31% as of Dec. 2025, which is 1% below its 10-year median of 25.65. GuruFocus rates BUGDF with a GF Score™ of 100/100 and a GF Value™ of $5.86. The stock has 1 warning sign investors should review. Among 628 Healthcare Providers & Services companies, Bumrungrad Hospital PCL ranks better than 89.49% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's ROE % distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Bumrungrad Hospital PCL (BUGDF) has a ROE % of 25.31% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Bumrungrad Hospital PCL and its competitors. This is near median its historical median of 25.65. Over the past decade, Bumrungrad Hospital PCL's ROE % has ranged from 6.25 to 32.21. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #66 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 10.5%.
Is Bumrungrad Hospital PCL's ROE % too high?
Bumrungrad Hospital PCL's current ROE % of 25.31% is near median its 10-year median of 25.65. Over the past 10 years, this metric has ranged from a low of 6.25 to a high of 32.21. The Healthcare Providers & Services industry median ROE % is 5.72. Bumrungrad Hospital PCL's value of 25.31% is 342.5% above this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #66 out of 628 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #66 out of 628 companies for ROE %. This places Bumrungrad Hospital PCL in the top 11% of its industry — outperforming the majority of peers. The industry median ROE % is 5.72. Bumrungrad Hospital PCL's value of 25.31% is 342.5% above this benchmark. Historically, Bumrungrad Hospital PCL's own ROE % has ranged from 6.25 to 32.21 over the past decade. While the company's 10-year median is 25.65 vs. the industry median of 5.72, Bumrungrad Hospital PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current ROE % of 25.31% is 342.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Bumrungrad Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current ROE % is 25.31%, which is near median its own 10-year median of 25.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current ROE % of 25.31%. The stock's GF Value™ is $5.86, compared to a current price of $4.75 — trading 18.9% below its estimated fair value. The current ROE % is 25.31%, which is near median its 10-year median of 25.65 and 342.5% above the Healthcare Providers & Services industry median of 5.72. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current ROE % is 25.31% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 18.9% below its estimated GF Value™ of $5.86.
Key valuation signals for BUGDF:
ROE %: 25.31% (near median its 10-year median of 25.65)
GF Value™: $5.86 vs. price of $4.75 (18.9% below fair value)
Industry Position: 342.5% above the Healthcare Providers & Services median (#66 of 628)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score
Get the complete analysis for BUGDF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
